Detalles de la búsqueda
1.
Factors associated with the designation of a health care proxy and writing advance directives for patients suffering from haematological malignancies.
BMC Palliat Care
; 13: 57, 2014.
Artículo
en Inglés
| MEDLINE | ID: mdl-25859160
2.
Long-term outcome of imatinib 400 mg compared to imatinib 600 mg or imatinib 400 mg daily in combination with cytarabine or pegylated interferon alpha 2a for chronic myeloid leukaemia: results from the French SPIRIT phase III randomised trial.
Leukemia
; 35(8): 2332-2345, 2021 08.
Artículo
en Inglés
| MEDLINE | ID: mdl-33483613
3.
Polypharmacy, potentially inappropriate medications and drug-drug interactions in geriatric patients with hematologic malignancy: Observational single-center study of 122 patients.
J Geriatr Oncol
; 9(1): 60-67, 2018 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-28851511
4.
Incidence of chronic myeloid leukemia and patient survival: results of five French population-based cancer registries 1980-2009.
Leuk Lymphoma
; 56(6): 1771-7, 2015 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-25535815
Resultados
1 -
4
de 4
1
Próxima >
>>